Extended Data Fig. 3 | Additional clinical correlates of plasma antibody
titres. a, Time between symptom onset and plasma collection in days plotted
against normalized AUC for IgG anti-RBD. r = –0.0261, P = 0.7533. b, Time
between symptom onset and plasma collection in days plotted against
normalized AUC for IgG anti-S. r = −0.1495, P = 0.0697. c, Time between
symptom onset and plasma collection in days plotted against normalized AUC
for IgM anti-S. r = 0.1496, P = 0.0695. d, Age plotted against AUC for IgM
anti-RBD. r = 0.0172, P = 0.8355. e, Age plotted against normalized AUC for IgG
anti-S. r = 0.1523, P = 0.0638. f, Age plotted against normalized AUC for IgM
anti-S. r = 0.0565, P = 0.4934. g, Duration of symptoms in days plotted against
normalized AUC for IgG anti-RBD. r = 0.1525, P = 0.0633. h, Duration of
symptoms in days plotted against normalized AUC for IgM anti-RBD.
r = −0.3187, P < 0.0001. i, Duration of symptoms in days plotted against
normalized AUC for IgG anti-S. r = 0.0329, P = 0.6904. j, Duration of symptoms
in days plotted against normalized AUC for IgM anti-S. r = 0.0824, P = 0. 317 7.
k, Severity of symptoms plotted against normalized AUC for IgG anti-RBD.
r = 0.2679, P = 0.0010. l, Severity of symptoms plotted against normalized AUC
for IgM anti-RBD. r = −0.1943, P = 0.0176. m, Severity of symptoms plotted
against normalized AUC for IgG anti-S. r = 0.1187 P = 0.1492. n, Severity of
symptoms plotted against normalized AUC for IgM anti-S. r = 0.1597, P = 0.0517.
All correlations were analysed by two-tailed Spearman’s tests; n = 149.